IQVIA Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 05:35PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

Good afternoon, everyone. My name is Luke Sergott. I cover life sciences tools and diagnostics at Barclays. It's my pleasure to introduce, this as not Ron, it's Mike Fedock. He's the Head of FP&A from -- and former CFO of the RDS business at IQVIA; and Nick Childs. Ron was sick today. So Mike's subbing in.

Michael Fedock - IQVIA Holdings Inc. - SVP of Financial Planning and Analysis

Yes. It was hard to express my dedication to IQVIA to agree upon to South Florida on short notice, but that's the sacrifices I make for Ron and Ari.

Questions and Answers:

Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst

All right. That's great. So I guess, as I've been doing with everybody else, let's just dive right into the macro here, go through -- let's start with the Ukraine-Russia invasion. Anything that you're seeing there from a demand perspective, any knock-on effects for trials, things like that?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot